Nkune, Nkune Williams Kruger, Cherie Ann Abrahamse, Heidi
Published in
Oncotarget
Photodynamic therapy (PDT) is a promising primary treatment option for colorectal cancer (CRC), however CRC is accelerated by resilient CRC stem-like cells, which decrease its efficacy. In recent years, researchers have shown an emerging interest in the anticancer stem cell effects of cannabidiol (CBD). This study developed a targeted nanobioconjug...
Datta, Subhamoy Patel, Manthan Kashyap, Sukesh Patel, Divyesh Singh, Umashankar
Published in
Oncotarget
Genomes of somatic cells in culture are prone to spontaneous mutations due to errors in replication and DNA repair. Some of these errors, such as chromosomal fusions, are not rectifiable and subject to selection or elimination in growing cultures. Somatic cell cultures are thus expected to generate background levels of potentially stable chromosoma...
Ogata, Ruiko Mori, Shiori Ohmori, Hitoshi Kishi, Shingo Fujiwara-Tani, Rina Sasaki, Takamitsu Nishiguchi, Yukiko Nakashima, Chie Goto, Kei Kawahara, Isao
...
Published in
Oncotarget
Linoleic acid (LA) has been shown to cause inflammation and promote development of colorectal cancer (CRC). Moreover, many literatures show that LA is associated with cancer metastasis. Metastatic cancer cells have high stemness, suggesting that LA might affect the stemness of cancer cells. In this study, we examined the effect of LA on the hedgeho...
Lou, Emil
Published in
Oncotarget
Wei, Xi Li, Qing Li, Ying Duan, Wei Huang, Chongbiao Zheng, Xiangqian Sun, Lei Luo, Jingtao Wang, Dong Zhang, Sheng
...
Published in
Oncotarget
Adeyelu, Tolulope Tosin Moya-Garcia, Aurelio A. Orengo, Christine
Published in
Oncotarget
Bladder cancer remains one of the most common forms of cancer and yet there are limited small molecule targeted therapies. Here, we present a computational platform to identify new potential targets for bladder cancer therapy. Our method initially exploited a set of known driver genes for bladder cancer combined with predicted bladder cancer genes ...
Booth, Laurence West, Cameron Moore, Robert P. Von Hoff, Daniel Dent, Paul
Published in
Oncotarget
GZ17-6.02 is presently undergoing clinical evaluation in solid tumors and lymphoma. The present studies were performed to define its biology in estrogen receptor positive breast cancer cells and to determine whether it interacted with palbociclib to enhance tumor cell killing. GZ17-6.02 interacted in an additive fashion with palbociclib to kill ER+...
Khosrowabadi, Elham Wenta, Tomasz Keskitalo, Salla Manninen, Aki Kellokumpu, Sakari
Published in
Oncotarget
Several distinct metastasis-associated glycosylation changes have been shown to promote cancer cell invasion and metastasis, the main cause of death of cancer patients. However, it is unclear whether their presence reflects cell- or tissue-specific variations for metastasis, or species needed to drive different phases of the metastatic cascade. To ...
Anisimov, Vladimir N.
Published in
Oncotarget
Rattner, Jodi I. Kopciuk, Karen A. Vogel, Hans J. Tang, Patricia A. Shapiro, Jeremy D. Tu, Dongsheng Jonker, Derek J. Siu, Lillian L. O’Callaghan, Chris J. Bathe, Oliver F.
...
Published in
Oncotarget
Purpose: Chemotherapy options for treating CRC have rapidly expanded in recent years, and few have predictive biomarkers. Oncologists are challenged with evidence-based selection of treatments, and response is evaluated retrospectively based on serial imaging beginning after 2–3 months. As a result, cumulative toxicities may appear in patients who ...